Study of an experimental anemia treatment for chemotherapy patients
Part of Blood & lymphatic clinical trials.
This study tests a new medication (SAL-0951) for treating low red blood cell counts (anemia) caused by chemotherapy in people with certain types of cancer that are not curable. It may help improve energy and reduce the need for blood transfusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must weigh at least 40 kg (about 88 pounds).
- You must have a type of cancer (not leukemia or myeloma) that is not curable, and you must be scheduled to receive chemotherapy for at least 6 more weeks.
- Your hemoglobin level must be 100 g/L or lower, and it must have dropped by at least 10 g/L after starting chemotherapy.
- Your iron levels (ferritin and transferrin saturation) must meet certain minimums.
- You must be in fairly good health (able to do light activities) and have a life expectancy of at least 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving iron (iron sucrose) can reduce anemia during chemotherapy before curative surgery. It may help you feel better and have smoother treatment by improving low blood counts caused by iron deficiency.
This Phase 1 trial tests how safe APG-5918 is, how the body processes it, and looks for early signs it may help people with certain types of anemia. It may include healthy volunteers and people with anemia, but the study is very selective to protect participants.
This trial is testing a new medicine called HS-20106 to see if it can improve anemia (low red blood cells) for people with certain types of MDS. If it works, it might reduce the need for blood transfusions.
This study tests an oral medication (AND017) to see if it can safely help raise hemoglobin levels in people with anemia caused by chemotherapy. If you have cancer (not leukemia) and are currently on chemo, this trial might help manage your anemia and improve your energy.
This trial tests a new medicine, SSS06, to help people whose red blood cell count drops too low after chemotherapy. It aims to reduce fatigue and other symptoms of anemia, making it easier to continue cancer treatment.
This trial tests a new pill, AND017, for people with cancer who have low red blood cell counts (anemia) and are not getting chemotherapy. The goal is to see if the drug helps raise hemoglobin levels and reduce fatigue.
Hear when a new Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.